US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      509 Recalls Helmets Due to Risk of Head Injury

      The recalled helmets fail to provide sufficient protection in the event of a crash, posing a risk of head injury. … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Ranbaxy Issues Voluntary Nationwide Recall of 41 Lots of Atorvastatin Calcium Tablets 10 Mg, 20 Mg and 40 Mg Due to Potential Presence of Foreign Substance

Ranbaxy Issues Voluntary Nationwide Recall of 41 Lots of Atorvastatin Calcium Tablets 10 Mg, 20 Mg and 40 Mg Due to Potential Presence of Foreign Substance

December 1, 2012 By The FDA Leave a Comment

Princeton, NJ — On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail level. The Company is taking this voluntary action as a precautionary measure due to the fact that we cannot exclude the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand (less than 1 mm in size). This information is available in Ranbaxy’s website at www.ranbaxyusa.com. The recall does not affect or relate to the 80 mg dosage strength of Atorvastatin Calcium Tablets.

The probability of an adverse event due to consumption of this product is unlikely but cannot be ruled out. Because of the size of the particles which may be present in the affected lots it is unlikely to cause a significant safety concern. However, the possibility of adverse experiences arising primarily due to physical irritation cannot be ruled out. As of this date, Ranbaxy has not received any reports of adverse events related to this recall.

The product is used to lower blood cholesterol and is packaged in plastic bottles, as 90 and 500 tablets per bottle. The affected lots of Atorvastatin Calcium Tablets and their respective NDC code, expiration date information are listed below. The product is a white colored tablet and can be identified by the imprint RX12 on 10 mg tablets, RX828 on 20 mg tablets and RX829 on 40 mg tablets. The product was distributed in the USA to wholesalers and retailers.

Ranbaxy has notified its distributors and retailers by e-mail/ FedEx and has arranged for return of the affected lots. Distributors/retailers have stopped further distribution of the affected lots and are in the process of returning any affected product to Ranbaxy.

Consumers with questions regarding this recall can contact Ranbaxy’s Customer Coordinator (Inmar) at 1-866-266-7623, Monday to Friday, 8:00 AM to 5:00 PM CST. Consumers should immediately contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Online:www.fda.gov/medwatch/report.htm
  • Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
  • Fax: 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Following is the list of affected lots:

Product Lot number Pack Size NDC # Expiry Date
ATORVASTATIN Calcium Tablets 10mg x 90 2436144 90’s Bottle 63304-827-90 31-Aug-14
ATORVASTATIN Calcium Tablets 10mg x 90 2436582 90’s Bottle 63304-827-90 31-Aug-14
ATORVASTATIN Calcium Tablets 10mg x 90 2441567 90’s Bottle 63304-827-90 31-Aug-14
ATORVASTATIN Calcium Tablets 10mg x 90 2441568 90’s Bottle 63304-827-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2436731 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437381 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437940 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437942 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437945 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437947 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437952 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437953 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437960 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2440676 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2440677 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2440680 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2440681 90’s Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 500 2437956 500’s Bottle 63304-829-05 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 500 2437957 500’s Bottle 63304-829-05 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 500 2440675 500’s Bottle 63304-829-05 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434265 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434266 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434824 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434826 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434827 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434828 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434829 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434830 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434831 90’s Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2436580 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2436725 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2436727 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2436729 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437377 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437380 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437941 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437943 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437944 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437949 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437950 90’s Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437955 90’s Bottle 63304-829-90 31-Aug-14

About Ranbaxy Inc.

Ranbaxy Inc. is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical company.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

509 Recalls Helmets Due to Risk of Head Injury

July 2, 2025 By The CPSC

SNLN Party Supply Toys Recalled Due to Ingestion Hazard; Risk of Serious Injury or Death; Federal Toy Standard Violation; Sold Exclusively on Amazon by Yiwu Dixikeji Douxiangongsi

July 2, 2025 By The CPSC

Harbor Freight Tools Recalls Predator 2000-Watt Power Stations Due to Shock Hazard

July 2, 2025 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Jeriflyer Pool Drain Covers Recalled Due to Risk of Serious Injury or Death from Entrapment Hazard; Violation of the Virginia Graeme Baker Pool and Spa Safety Act; Sold on Amazon by Junjuanshop

July 2, 2025 By The CPSC

Positec Recalls Electric Corded Chainsaws and Pole Saws Due to Laceration Hazard

July 2, 2025 By The CPSC

Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging

June 27, 2025 By The FDA

Shang Hao Jia, Inc. Issues Allergy Alert on Undeclared Sesame in Danshi Brand Spicy Shredded Tofu

June 25, 2025 By The FDA

The Coleman Company Recalls Converta Camping Cots and Converta Camping Suspension Stretchers Due to Laceration and Amputation Hazards; Imported by Newell Brands

June 25, 2025 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Shang Hao Jia, Inc. Issues Allergy Alert on Undeclared Sesame in Danshi Brand Spicy Shredded Tofu

June 25, 2025 By The FDA

The Coleman Company Recalls Converta Camping Cots and Converta Camping Suspension Stretchers Due to Laceration and Amputation Hazards; Imported by Newell Brands

June 25, 2025 By The CPSC

iHerb Recalls Bottles and Blister Packs of California Gold Nutrition Iron Supplements Due to Risk of Serious Injury or Death from Child Poisoning; Violation of Federal Standard for Child Resistant Packaging

June 25, 2025 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • 509 Recalls Helmets Due to Risk of Head Injury
  • SNLN Party Supply Toys Recalled Due to Ingestion Hazard; Risk of Serious Injury or Death; Federal Toy Standard Violation; Sold Exclusively on Amazon by Yiwu Dixikeji Douxiangongsi
  • Harbor Freight Tools Recalls Predator 2000-Watt Power Stations Due to Shock Hazard
  • DEWALT Recalls Grinder Flap Discs Due to Laceration and Injury Hazards
  • Trane Recalls Gas/Electric Packaged Units Due to Risk of Gas Leak, Fire Hazard
  • Jeriflyer Pool Drain Covers Recalled Due to Risk of Serious Injury or Death from Entrapment Hazard; Violation of the Virginia Graeme Baker Pool and Spa Safety Act; Sold on Amazon by Junjuanshop
  • Positec Recalls Electric Corded Chainsaws and Pole Saws Due to Laceration Hazard
  • Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging
  • Shang Hao Jia, Inc. Issues Allergy Alert on Undeclared Sesame in Danshi Brand Spicy Shredded Tofu
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in